National Bank of Canada
NVAX icon

National Bank of Canada’s Novavax NVAX Stock Holding History

National Bank of Canada’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-1,481
Closed -$1.19M – 3059
2024
Q4 		$1.19M Sell
1,481
-2,613
-64% -$25.2K ﹤0.01% 1274
2024
Q3 		$5.17M Sell
4,094
-7,849
-66% -$101K 0.01% 836
2024
Q2 		$15.2M Buy
11,943
+1,185
+11% +$11.9K 0.02% 455
2024
Q1 		$9.55M Sell
10,758
-5,339
-33% -$24.8K 0.01% 632
2023
Q4 		$8.1M Buy
16,097
+3,315
+26% +$20.3K 0.01% 624
2023
Q3 		$9.06M Buy
12,782
+10,511
+463% +$84K 0.01% 635
2023
Q2 		$1.68M Sell
2,271
-9,668
-81% -$76K ﹤0.01% 1029
2023
Q1 		$8.27M Buy
11,939
+10,939
+1,094% +$101K 0.02% 464
2022
Q4 		$1.03M Buy
+1,000
New +$17.6K ﹤0.01% 1071

Other funds holding NVAX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
S
Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
TCMG
TSP Capital Management Group Summit, New Jersey $418M AUM 68.45% 1-Year Est. Return
JAM
Jupiter Asset Management London, United Kingdom $20.2B AUM 29.18% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
MAM
Monaco Asset Management Monaco $1.26B AUM 60.23% 1-Year Est. Return
EP
Edgestream Partners Princeton, New Jersey $3.37B AUM 20.71% 1-Year Est. Return

National Bank of Canada's NVAX Position: Q2 2026 in Review

National Bank of Canada increased its Novavax (NVAX) stake by 8.3% in Q2 2026, buying an estimated $1.53K and bringing the position to 2,219 shares worth $20.9K. The position accounts for ﹤0.01% of the portfolio, ranked #2236.

National Bank of Canada first reported a position in NVAX in Q4 2021 and has held it in 18 quarters since. The position peaked at $6.26M in Q2 2023. 151 funds tracked by Wall St. Rank hold NVAX as of Q2 2026.

  • National Bank of Canada held 2,219 shares of Novavax worth $20.9K as of Q2 2026.
  • National Bank of Canada bought 171 Novavax shares in Q2 2026, an estimated $1.53K.
  • Novavax made up ﹤0.01% of National Bank of Canada's portfolio in Q2 2026, its #2236 holding.
  • National Bank of Canada first reported a position in Novavax in Q4 2021 and has held it in 18 quarters since.
  • National Bank of Canada's Novavax position peaked at $6.26M in Q2 2023.
  • 151 funds tracked by Wall St. Rank held Novavax as of Q2 2026.

Based on National Bank of Canada's 13F filing for Q2 2026, filed 10 Aug 2026.